The Side Effect No One Warned Him About

The Man Who Never Gambled

For sixty-eight years, Vincent Oyelaran had been, by his own daughter's account, the least impulsive man anyone in the family knew. A retired structural engineer, he balanced his checkbook by hand out of habit even after the bank offered to do it automatically. He'd never bought a lottery ticket. He considered casinos, when the topic came up at all, a mildly baffling way for people to lose money on purpose.

So when his daughter, Adaeze, thirty-six, started noticing unexplained withdrawals from his account while helping him manage bills after his Parkinson's diagnosis, her first assumption wasn't that he'd developed a gambling habit. It didn't fit. Her second assumption was that someone was exploiting him — a scam, elder fraud, something being done to him rather than something he was doing himself.

The Pattern She Couldn't Explain

Vincent had been prescribed a dopamine agonist eight months earlier to manage his Parkinson's symptoms, a class of medication that supplements dopamine activity in the brain to address the movement symptoms of the disease. Within weeks of increasing his dose, he'd started visiting a casino near his retirement community — first occasionally, then, by month four, most evenings.

Adaeze found four-figure withdrawals over consecutive weeks and confronted him gently, expecting embarrassment or a request for help fending off a scammer. Instead, her father seemed almost detached from his own behavior, describing an urge to be at the machines that he characterized less as desire and more as a kind of pull he didn't fully understand himself.

"He kept saying, 'I know it doesn't make sense, I don't even enjoy it the way you'd think,' and that's what convinced me something was actually wrong — not that he was lying to me, but that he sounded confused by himself."

Finding the Answer in the Fine Print

Adaeze's research, prompted by that confusion rather than any suspicion of fraud, led her to something she hadn't expected: dopamine agonist medications, prescribed widely and safely for Parkinson's disease and restless leg syndrome, carry a well-documented but relatively rare side effect known as impulse control disorder — a cluster of behaviors including compulsive gambling, compulsive shopping, hypersexuality, and binge eating that can emerge in patients with no prior history of any of them, sometimes within weeks of starting or increasing the medication.

She brought this to Vincent's neurologist directly, describing the specific pattern: sudden onset, no personal or family history of gambling, behavior the patient himself found bewildering. The neurologist confirmed it immediately as a recognized, if underdiscussed, side effect and adjusted Vincent's dosage, incorporating a different medication strategy for his Parkinson's symptoms under close supervision.

The Reversal

Within roughly six weeks of the dosage adjustment, Vincent's casino visits stopped — not gradually, but almost as abruptly as they'd started. He described the change himself as the pull simply switching off, the way a persistent low hum in a room stops and you only then notice how loud it had been. He has not gambled since, more than a year later, and remains adamant that at no point during those eight months did the behavior feel like a moral lapse from the inside — it felt, he says, like being steered by something outside his own preferences.

What the Family Wants Doctors to Say Out Loud

Adaeze's frustration, in retrospect, isn't with her father or with the medication, which continues to help manage his Parkinson's symptoms effectively at the adjusted dose. It's with the fact that no one — not the prescribing neurologist, not the pharmacy handout — had mentioned impulse control changes as something to actively watch for, despite it being a documented, labeled risk of the drug class.

She now tells other families managing a relative's Parkinson's or restless leg syndrome treatment to ask specifically, at the time of prescribing, whether the medication carries this risk, and to monitor bank statements for sudden, out-of-character spending in the months after any dose change — not out of suspicion, but because this particular side effect can look exactly like a personal failing while having nothing to do with character at all. If it happens, the first call should be to the prescribing doctor, not a moral reckoning with the patient.